Design Therapeutics (DSGN) Other financing activities (2021 - 2026)
Design Therapeutics (DSGN) reported Other financing activities of $27000.0 for Q1 2026, up 17.39% on a YoY basis from $23000.0 in Q1 2025, and down 85.16% sequentially from $182000.0 in Q4 2025.
Design Therapeutics (DSGN) Other financing activities (2021 - 2026) Analysis & Trends
Design Therapeutics (DSGN) has 6 years of Other financing activities data on file, last reported at $27000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 17.39% year-over-year to $27000.0; the trailing twelve-month figure through Mar 2026 stood at $246000.0 (up 530.77% YoY), and the FY2025 full-year result was $242000.0, up 572.22% from the prior year.
- Other financing activities fell to $27000.0 in Q1 2026, from $182000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $383000.0 in Q4 2023 to a low of -$7000.0 in Q4 2022.
- A 5-year average of $77000.0 and a median of $23000.0 in 2025 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities sank 100.0% in 2022 and surged 5571.43% in 2023, its largest moves.
- Tracing DSGN's Other financing activities over 5 years: stood at -$7000.0 in 2022, then surged by 5571.43% to $383000.0 in 2023, then sank by 97.65% to $9000.0 in 2024, then jumped by 1922.22% to $182000.0 in 2025, then plunged by 85.16% to $27000.0 in 2026.
- Business Quant data shows DSGN's Other financing activities at $27000.0 in Q1 2026, $182000.0 in Q4 2025, and $37000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Design Therapeutics | 714.48 Mn | 491.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 182,000.00 |
| Dec 31, 2025 | 182,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 383,000.00 |
| Dec 31, 2023 | 383,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Sep 30, 2023 | 13,000.00 |